Amgen settles with FTC over US$28 billion deal
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
This approval has come from the company's finished dosage form manufacturing facility
Erythromycin tablets is used to prevent and treat infections in many different parts of the body
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
Health Assurance is a unique healthcare model that combines health insurance with preventive healthcare with a focus on keeping people healthy while providing sick care for them when needed
Robots make it to the healthcare conference panel, reflecting the future potential of technology
Amneal’s site in Matoda is one of the company’s 12 pharmaceutical manufacturing facilities
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
The inspection has concluded successfully on 1st September 2023 without any critical/major observation
Dr. Laurent Leksell, Elekta’s Founder and Chairman of the Board, and IAEA’s Director General, Dr. Rafael Mariano Grossi meet in Stockholm to discuss reducing the global cancer burden
Subscribe To Our Newsletter & Stay Updated